Top Nuclear Medicine Companies

The escalating prevalence of chronic diseases, including cancer, cardiovascular disorders, and neurological conditions, is a major driver of the global nuclear medicine market. These diseases often require early detection and ongoing monitoring to improve patient outcomes. Nuclear medicine techniques, such as positron emission tomography (PET) and single-photon emission computed tomography (SPECT), provide highly precise diagnostic imaging and functional insights, enabling clinicians to tailor treatment plans. As the burden of chronic illnesses increases globally due to aging populations and lifestyle changes, healthcare providers expand their use of nuclear medicine.

Industry Overview

According to SkyQuest Technology “Global Nuclear Medicine Market” By Product (Diagnostics and Therapeutics) By Application (Cardiology, Neurology, Oncology, Thyroid, Lymphoma, Bone Metastasis, Endocrine Tumor, Pulmonary Scans, Urology, and Others), By End Use, By Region - Industry Forecast 2025-2032,” global nuclear medicine market is projected to grow at a CAGR of over 10.7% by 2032, on account of urgent need for automating quantified data. Technological innovation in nuclear medicine imaging systems is a key factor shaping the market. Modern hybrid imaging technologies, such as PET/CT and SPECT/CT scanners, enhance diagnostic accuracy by combining functional and anatomical information.

Top 10 Global Nuclear Medicine Companies

1. Cardinal Health

Cardinal Health is a global leader in healthcare services and products, committed to improving patient care and supporting healthcare providers worldwide. Founded in 1971 and headquartered in Dublin, Ohio, the company operates across more than 60 countries. Its core offerings include radiopharmaceutical distribution, nuclear pharmacy services, and theranostic solutions, serving hospitals, clinics, and research institutions. Cardinal Health has recently expanded its nuclear medicine portfolio, enhancing access to diagnostic and therapeutic agents, while investing in innovative supply chain solutions and patient support programs to strengthen global healthcare delivery and market growth.

2. GE Healthcare

GE Healthcare is a global leader in medical technologies and digital solutions, dedicated to improving patient outcomes and transforming healthcare delivery worldwide. Founded in 1892 and headquartered in Chicago, Illinois, the company operates in over 140 countries. Its core offerings include molecular imaging systems, radiopharmaceuticals, and AI-enabled diagnostic solutions, supporting hospitals, clinics, and research centers. GE Healthcare has recently advanced its nuclear medicine portfolio with cutting-edge PET/CT and SPECT/CT scanners, while integrating AI-driven imaging and workflow optimization tools, enabling more accurate diagnostics, enhanced patient care, and efficient clinical operations.

3. Siemens Healthineers

Siemens Healthineers is a global leader in medical technology and healthcare solutions, committed to improving patient care and advancing clinical outcomes worldwide. Founded in 1847 and headquartered in Malvern, Pennsylvania, the company operates in over 70 countries. Its core offerings include PET/CT and SPECT/CT imaging systems, nuclear cardiology solutions, and AI-enabled diagnostic tools. Siemens Healthineers has recently focused on hybrid imaging technologies and digital health innovations, enhancing diagnostic accuracy, workflow efficiency, and patient safety, while continuously investing in research, development, and global clinical support to drive growth and innovation in nuclear medicine.

4. NorthStar Medical Radioisotopes

NorthStar Medical Radioisotopes is a leading provider of therapeutic and diagnostic radioisotopes, dedicated to advancing nuclear medicine and improving patient outcomes worldwide. Founded in 2006 and headquartered in Beloit, Wisconsin, the company specializes in the development, production, and supply of high-quality radioisotopes for clinical and research applications. Its core offerings include therapeutic radioisotopes, contract development and manufacturing (CDMO) services, and commercial-scale isotope production. NorthStar Medical Radioisotopes continues to innovate in radiopharmaceutical supply chains and regulatory compliance, ensuring reliable access to critical isotopes while supporting growth and innovation in global nuclear medicine.

5. Jubilant Radiopharma

Jubilant Radiopharma is a global leader in radiopharmaceuticals, dedicated to advancing nuclear medicine and enhancing patient care worldwide. Founded in 2019 and headquartered in Yardley, Pennsylvania, the company focuses on the development, manufacturing, and commercialization of diagnostic and therapeutic radiopharmaceuticals. Its core offerings include a network of radiopharmacies, innovative radiopharmaceutical formulations, and comprehensive nuclear medicine solutions. Jubilant Radiopharma continues to expand its portfolio and production capabilities, supporting clinical trials, regulatory compliance, and global distribution, enabling healthcare providers to deliver accurate diagnostics and effective treatments, driving growth in the nuclear medicine market.

6. Eckert & Ziegler Radiopharma

Eckert & Ziegler Radiopharma is a global provider of radiopharmaceuticals and related services, dedicated to advancing nuclear medicine and improving patient outcomes worldwide. Founded in 1997 and headquartered in Atlanta, Georgia, the company specializes in the development, manufacturing, and supply of high-quality radiopharmaceuticals and chemicals for diagnostic and therapeutic applications. Its core offerings include radiosynthesis, quality control, GMP manufacturing, and regulatory support. Eckert & Ziegler Radiopharma continues to innovate in radiopharmaceutical production and research, supporting healthcare providers with reliable solutions that enhance diagnostics, therapy, and overall growth in the nuclear medicine market.

7. Lantheus Holdings

Lantheus Holdings is a global leader in diagnostic and therapeutic radiopharmaceuticals, committed to improving patient outcomes and advancing nuclear medicine worldwide. Founded in 1956 and headquartered in North Billerica, Massachusetts, the company develops, manufactures, and commercializes a wide range of imaging and therapeutic agents. Its core offerings include diagnostic radiopharmaceuticals, therapeutic radiopharmaceuticals, AI-enabled imaging solutions, clinical trial support, and patient and physician education programs. Lantheus Holdings continues to expand its portfolio and invest in innovative technologies, providing healthcare providers with reliable solutions that enhance diagnostics, treatment, and overall growth in the nuclear medicine market.

8. Sotera Health (Nordion)

Sotera Health, through its Nordion division, is a global leader in radiopharmaceuticals, sterilization solutions, and radiation therapy services, dedicated to advancing healthcare and improving patient outcomes worldwide. Founded in 1999 and headquartered in Twinsburg, Ohio, the company specializes in the supply of Cobalt-60, gamma irradiation systems, and sterilization services for medical applications. Its core offerings include radiopharmaceutical supply, radiation therapy solutions, sterilization services, equipment maintenance, cold chain logistics, and regulatory compliance support. Sotera Health continues to innovate in radiation and nuclear medicine solutions, ensuring safe, reliable, and effective healthcare delivery globally.

9. Telix Pharmaceuticals

Telix Pharmaceuticals is a global biopharmaceutical company focused on the development and commercialization of imaging and therapeutic radiopharmaceuticals, dedicated to improving patient outcomes in oncology and other serious diseases worldwide. Founded in 2009 and headquartered in Indianapolis, Indiana, the company specializes in FDA-approved diagnostic agents and innovative therapeutic solutions. Its core offerings include imaging radiopharmaceuticals, therapeutic radiopharmaceuticals, clinical trial supply, radiopharmaceutical manufacturing, regulatory support, and market access services. Telix Pharmaceuticals continues to expand its portfolio and invest in research, enabling healthcare providers to deliver accurate diagnostics and effective targeted therapies globally.

10. NeuroOne Medical Technologies

NeuroOne Medical Technologies is a global innovator in neurosurgical and neurodiagnostic solutions, dedicated to improving patient care and advancing neurological treatments worldwide. Founded in 2009 and headquartered in Eden Prairie, Minnesota, the company develops cutting-edge neurostimulation devices, diagnostic tools, and surgical robotics for complex neurological conditions. Its core offerings include neurostimulation devices, neurodiagnostic tools, surgical robotics, device research and development, clinical training support, and product maintenance services. NeuroOne continues to drive innovation in neurological care, providing healthcare providers with advanced technologies that enhance precision, safety, and outcomes in neurosurgery and related treatments.

Other Leading Global Nuclear Medicine Companies

• Siemens Healthineers
• Bayer AG
• Bracco Imaging S.p.A.
• OranoMed
• Applied Molecular Therapies
• Alpha Tau Medical              
• Isotopia Molecular Imaging
• Sensus Healthcare
• Canon Medical Systems Corporation
• Mevion Medical Systems

Conclusion

The global nuclear medicine market is poised for significant growth, driven by the rising prevalence of chronic diseases and the urgent need for precise diagnostic and therapeutic solutions. Innovations in PET/CT and SPECT/CT imaging, along with AI integration, enhance diagnostic accuracy, workflow efficiency, and patient outcomes. Leading companies, including Cardinal Health, GE Healthcare, Siemens Healthineers, and NorthStar Medical Radioisotopes, are expanding their portfolios through advanced radiopharmaceuticals, hybrid imaging systems, and global distribution networks. As technological advancements and clinical adoption continue, nuclear medicine is set to play an increasingly pivotal role in healthcare, offering improved diagnostics and targeted therapies worldwide.